Previous close | 1.3500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 500.00 |
Expiry date | 2024-08-02 |
Day's range | 1.3500 - 1.3500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
(Bloomberg) -- S&P Global Inc. named Martina Cheung, the president of its credit ratings division, as its next chief executive officer. Most Read from BloombergBiden’s Disastrous Debate Accelerates Doubts Over CandidacyBiden Struggles as He Spars With Trump on Economy: Debate TakeawaysBiden Struggles Against Trump in High-Stakes 2024 DebateDemocrats Question Replacing Biden: Here’s How It Could WorkSupreme Court Poised to Allow Emergency Abortions in IdahoCheung will become CEO effective Nov. 1,
Cheung, who has held multiple leadership roles at S&P Global in her 14-year stint, will succeed Douglas Peterson, the company's chief executive since 2013. S&P Global announced that retiring CEO Peterson will remain with the board until May 2025, and will be a special adviser to the company till Dec. 31, 2025. This trend bodes well for companies such as S&P Global, known for its rating agency business and stock market indexes.